Clinical Trials Browser

Disease, Neoplasms, Genetic Predisposition to Disease

NCT04053114 2025-08-29

MOLTHYSO

Withdrawn

GynecologicHead & Neck

Teratoma, Ovarian, Ovarian Neoplasms, Struma Ovarii, Thyroid Neoplasms

NCT06582108 2024-09-03

ROAR

Not yet recruiting

190 enrolled

Gynecologic

Vulvar Neoplasms

NCT05111067 2024-08-21

Molecular Subtyping of Triple-negative Breast Cancer and African Ancestry-related Immunogenicity

Completed

120 enrolled

Breast

Triple Negative Breast Neoplasms

NCT05605379 2024-08-14

CML Piramid

Recruiting

88 enrolled

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT05390112 2022-05-25

Mona-Lisa

Unknown

167 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT04215913 2020-01-02

PSC

Unknown

300 enrolled

Thoracic

Lung Neoplasms

NCT00984035 2018-09-11

Investigation of Cisplatin-Related Kidney Toxicity

Completed

102 enrolled

Tumor-Agnostic

Neoplasms

NCT00898742 2013-04-02

Gene and Protein Expression Patterns in Predicting Response to Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer

Terminated

58 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Salivary Gland Neoplasms

NCT00566566 2007-12-03

Adipokines as Predictors of the Metabolic Syndrome in ALL Survivors

Unknown

150 enrolled

Other hematologic neoplasm

Cardiovascular Diseases, Diabetes Mellitus, Leukemia, Metabolic Syndrome

Clinical Trials

Genetic Investigation of Cancer Predisposition

MOLTHYSO

ROAR

Molecular Subtyping of Triple-negative Breast Cancer and African Ancestry-related Immunogenicity

CML Piramid

Mona-Lisa

PSC

Investigation of Cisplatin-Related Kidney Toxicity

Gene and Protein Expression Patterns in Predicting Response to Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer

Adipokines as Predictors of the Metabolic Syndrome in ALL Survivors